37. Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Adrenoleukodystrophy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34372-6
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

316. Integration Site Distribution of Lentiviral Vector in Gene Therapy for X-Adrenoleukodystrophy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Generation of a New Gateway-Compatible Inducible Lentiviral Vector Platform Allowing Easy Derivation of Co-Transduced Cells

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2016English

Optimization of a Retroviral Vector for Transduction of Human CD34 Positive Cells.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2006English

Efficient Expansion of Human Keratinocyte Stem/Progenitor Cells Carrying a Transgene With Lentiviral Vector

Stem Cell Research and Therapy
GeneticsCell BiologyMolecular BiologyBiochemistryMedicineMolecular Medicine
2013English

Stable Transduction of Quiescent CD34+CD38- Human Hematopoietic Cells by HIV-1-based Lentiviral Vectors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Lentiviral-Transduced Human Mesenchymal Stem Cells Persistently Express Therapeutic Levels of Enzyme in a Xenotransplantation Model of Human Disease

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2008English

Outcomes of Gene Therapy for Severe Sickle Cell Disease (SCD) via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex Vivo With a Lentiviral ßAT87Q-Globin Vector

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Long-Term Deregulated Human Hematopoiesis in Goats Transplanted in Utero With BCR-ABL-transduced Lin−CD34+ Cord Blood Cells

Cell Research
Cell BiologyMolecular Biology
2013English

354. The Integration Profile of Lentiviral Vector in CD34+ Hematopoietic Stem Cells Is Dependent on the Cell Cycle Status of the Target Cell

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy